Cold & Cough Remedies (Pharmacies) - Estonia

Revenue in the Cold & Cough Remedies market is projected to reach US$24.07m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 8.13%, resulting in a market volume of US$35.58m by 2029.
In global comparison, most revenue will be generated China (US$7.83bn in 2024).
In relation to total population figures, per person revenues of US$18.25 are generated in 2024.

Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies (Pharmacies) market in Estonia has been experiencing steady growth in recent years.

Customer preferences: Customers in Estonia have shown a strong preference for over-the-counter cold and cough remedies purchased from pharmacies. This preference can be attributed to the convenience and accessibility of pharmacies, which are widely available throughout the country. Additionally, customers value the expertise and advice provided by pharmacists when selecting the most suitable remedies for their symptoms.

Trends in the market: One of the key trends in the Cold & Cough Remedies market in Estonia is the increasing demand for natural and herbal remedies. Customers are becoming more health-conscious and are seeking alternative options to traditional pharmaceutical products. This trend aligns with the global shift towards natural and organic products, driven by a growing awareness of the potential side effects of certain medications. Another trend in the market is the rising popularity of combination products that offer multiple benefits in a single remedy. Customers are looking for convenience and efficiency, and combination products that address multiple symptoms are seen as a cost-effective solution. This trend is driven by the desire to simplify the treatment process and reduce the number of products needed.

Local special circumstances: One of the unique factors influencing the Cold & Cough Remedies market in Estonia is the country's climate. Estonia experiences long and cold winters, which often lead to an increase in cold and cough cases. This seasonal demand creates a consistent market for cold and cough remedies throughout the winter months. Additionally, the high level of healthcare awareness and access to healthcare services in Estonia contributes to the demand for cold and cough remedies. The country has a well-developed healthcare system, and customers are proactive in seeking treatment for their symptoms. This creates a favorable environment for the growth of the Cold & Cough Remedies market.

Underlying macroeconomic factors: The growth of the Cold & Cough Remedies market in Estonia is also influenced by macroeconomic factors. The country has experienced a stable economy in recent years, with increasing disposable incomes and a growing middle class. As a result, customers have more purchasing power and are willing to spend on healthcare products, including cold and cough remedies. Furthermore, the aging population in Estonia is contributing to the growth of the Cold & Cough Remedies market. With an aging population, there is a higher prevalence of chronic respiratory conditions and weakened immune systems, leading to a higher demand for cold and cough remedies. In conclusion, the Cold & Cough Remedies market in Estonia is developing due to customer preferences for over-the-counter remedies, increasing demand for natural and combination products, local special circumstances such as the climate and healthcare access, and underlying macroeconomic factors such as stable economy and aging population.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.